Searched for
PRAVEEN SIKRI OF IKRIS PHARMA NETWORK
Talent twist: Silicon Valley's India story takes an unexpected turnThe prospective appointment of Kunal Shah to a leadership position at WhatsApp exemplifies an emerging pattern: Indian founders are increas...- Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
- Lucknow fire incident: FIR cites illegal commercial use, single entry/exit in building that claimed 15 livesA devastating fire in Lucknow's Aliganj building, claiming 15 lives, has led to an FIR alleging severe negligence. The building, housing mu...
- Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...
- Manu Chandra's Sauce, the VC making a feast of small servingsSauce VC is set to make an estimated Rs 500-550 crore from L'Oréal's acquisition of Innovist, validating founder Manu Chandra's strategy of...
- HealthQuad raises Rs 550 crore, eyes Rs 1,700 crore fundHealthQuad has secured Rs 550 crore for its third fund. The venture capital firm aims to raise Rs 1,700 crore to back early-growth companie...
- Time for long-term investors to look at them again? 9 NBFC stocks with upside potential of up to 22%The reason NBFC stocks reacted quickly to the easing of the US-Iran war risk is not difficult to understand. For a lender, macro relief tra...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsFrom a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- AI in Hungary could unlock productivity gains of €15 billion: McKinseyMcKinsey projects AI could boost Hungary's productivity by €15 billion by 2030, helping close the gap with European neighbours. However, la...
- BSF & BGB committed to maintaining peace along Indo-Bangladesh borderIndia's Border Security Force and Border Guard Bangladesh concluded their annual meeting. Both forces committed to peace and stability alon...
- India, Bangladesh reaffirm commitment to secure borders at four-day BSF-BGB conferenceIndia's Border Security Force and Border Guard Bangladesh concluded a four-day meeting reaffirming their commitment to border peace. Both f...
- Issues related to illegal, forcible border crossings discussed during India-Bangladesh talks: BSFIndia and Bangladesh border guards met in New Delhi to address critical issues. Discussions focused on preventing border crimes, including ...
- Ahead of Market: 10 things that will decide stock market action on FridayIndian equities witnessed sharp swings before ending lower amid expiry-day volatility and rising geopolitical concerns. Profit booking in b...
- Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
- Hetero partners with Richter to develop, market Semaglutide injection globallyHyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...
- India joins elite heavy-haul railway club, targets lower logistical costs: DFCCIL MDIndia now operates heavy-haul freight railways, joining a select global group. The nation is adopting advanced technologies and global best...
Load More
